Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
The Journal of Urology
|
July 14, 2021
Reply by Authors
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology
|
May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Journal of Geriatric Oncology
|
August 21, 2022
The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study
Shlomit S Shachar, Gil Bar-Sela, Avivit Peer, et al.
Clinical Genitourinary Cancer
|
July 29, 2014
Activity of cabazitaxel after docetaxel and abiraterone acetate therapy in patients with castration-resistant prostate cancer
Avishay Sella, Tal Sella, Avivit Peer, et al.
The Journal of Urology
|
June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
David Margel, Avivit Peer, Yaara Ber, et al.
The Journal of Urology
|
September 6, 2019
Reply By Authors
David Margel, Avivit Peer, Yaara Ber, et al.
The Israel Medical Association Journal : IMAJ
|
July 26, 2014
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors
Dana Livne-Segev, Maya Gottfried, Natalie Maimon, et al.
Cancers
|
September 3, 2020
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
Cancers
|
April 23, 2022
Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. <i>Cancers</i> 2020, <i>12</i>, 2447
Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
The Oncologist
|
September 14, 2012
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram
Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
The Journal of Urology
|
July 14, 2021
Reply by Authors
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
The Journal of Urology
|
May 25, 2021
Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Karin Lifshitz, Yaara Ber, Chen Shenhar, et al.
Journal of Geriatric Oncology
|
August 21, 2022
The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study
Shlomit S Shachar, Gil Bar-Sela, Avivit Peer, et al.
Clinical Genitourinary Cancer
|
July 29, 2014
Activity of cabazitaxel after docetaxel and abiraterone acetate therapy in patients with castration-resistant prostate cancer
Avishay Sella, Tal Sella, Avivit Peer, et al.
The Journal of Urology
|
June 13, 2019
Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
David Margel, Avivit Peer, Yaara Ber, et al.
The Journal of Urology
|
September 6, 2019
Reply By Authors
David Margel, Avivit Peer, Yaara Ber, et al.
The Israel Medical Association Journal : IMAJ
|
July 26, 2014
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors
Dana Livne-Segev, Maya Gottfried, Natalie Maimon, et al.
Cancers
|
September 3, 2020
Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
Cancers
|
April 23, 2022
Correction: Bar-Sela et al. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. <i>Cancers</i> 2020, <i>12</i>, 2447
Gil Bar-Sela, Idan Cohen, Salvatore Campisi-Pinto, et al.
The Oncologist
|
September 14, 2012
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram
Daniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.
Page
of 5